Abstract
A strong relationship was previously described between the nocturnal oscillations of plasma renin activity (PRA) and the sleep cycles, with levels of PRA that increase during non rapid eye movement sleep and decrease during rapid eye movement sleep. This study was designed to determine whether ritanserin, a 5-hydroxytryptamine-2 (5-HT2) receptor antagonist known to increase slow wave sleep both in human and in animals and to decrease plasma renin activity response to serotonergic stimulation in the rat, would uncouple this relationship. Eight subjects underwent two randomized night studies after having received either placebo or 5 mg ritanserin administered in the morning. They were subjected to 8 hour polysomnography, including spectral analysis of the electroencephalogram and to continuous blood sampling. Blood was sampled from 2300 to 700h every 10 min and plasma renin activity (PRA) was measured by radioimmunoassay of angiotensin I. The nocturnal profiles were analysed using the pulse detection program ULTRA. Ritanserin produced the expected increase in slow wave sleep (SWS) duration (132±10 min under ritanserin vs 72±9 min under placebo; p<0.001) and a significant increase in delta relative power (69±2% under ritanserin vs 60±2% under placebo; p<0.01). The mean overnight PRA levels had a tendency to decrease under ritanserin (1.66±0.34 ngAngl/ml per h under ritanserin vs 1.48±0.31 ngAngl/ml per h under placebo; p=0.08). Individual PRA oscillations were preserved and remained strongly associated with delta power oscillations. PRA peak levels were similar in both experimental conditions, but the absolute amplitude of the oscillations was decreased under ritanserin (1.50±0.36 ngAngl/ml per h vs 1.04±0.14 ngAngl/ml per h; p<0.05). These results demonstrate that ritanserin, at a dose that augments delta power, only weakly affects renin release, which suggests that 5-HT2 receptors are only partially involved in the processes coupling renin release and SWS and that other mechanisms probably control the sleep-associated variations in PRA.
Similar content being viewed by others
References
Hackenthal E., Paul M., Ganten D., Taugner R. Morphology, physiology, and molecular biology of renin secretion. Physiol. Rev. 70: 1067, 1990.
Brandenberger G., Follenius M., Goichot B., Saini J., Spiegel K., Ehrhart J., Simon C. Twenty-four-hour profiles of plasma renin activity in relation to the sleep-wake cycle. J. Hypertens. 12: 277, 1994.
Brandenberger G., Follenius M., Simon C., Ehrhart J., Libert J.P. Nocturnal oscillations in plasma renin activity and REM-NREM sleep cycles in humans: a common regulatory mechanism? Sleep 11: 242, 1988.
Brandenberger G., Krauth M.O., Ehrhart J., Libert J.P., Simon C., Follenius M. Modulation of episodic renin release during sleep in humans. Hypertension 15: 370, 1990.
Follenius M., Krieger J., Krauth M.O., Sforza F., Brandenberger G. Obstructive sleep apnea treatment: peripheral and central etfects of plasma renin activity and aldosterone. Sleep 14: 211, 1991.
Schulz H., Brandenberger G., Gudewill C., Hasse D., Kiss E., Löhr K., Pollmächer T., Follenius M. Plasma renin activity and sleep-wake structure of narcoleptic patients and control subjects under continuous bedrest. Sleep 15: 423, 1992.
Brandenberger G., Imbs J.L., Libert J.P., Ehrhart J., Simon C., Santoni J. Ph., Follenius M. Nocturnal oscillations in plasma renin activity during sleep in hypertensive patients: The influence of Perindopril. J. Endocrinol. Invest. 13: 559, 1990.
Jouvet M. Biogenic amines and the states of sleep. Science 163: 32, 1969.
Ursin R. The effects of 5-hydroxytryptophan and L-tryptophan on wakefulness and sleep patterns in the cat. Brain. Res. 106: 105, 1976.
Cespuglio R., Houdouin F., Oulerich M., El Mansari M., Jouvet M. Axonal and somato-dendritic modalities of serotonin release: their involvement in sleep preparation, triggering and maintenance. J. Sleep Res. 1: 150, 1992.
Sharpley A.L., Solomon R.A., Fernando A.I., da Roza D.J.M., Cowen P.J. Dose-related etfects of selective 5-HT2 receptor antagonists on slow wave sleep in humans. Psychopharmacology 101: 568, 1990.
Idzikowski C., Mills F.J., James R.J. A dose-response study examining the effects of ritanserin on human slow wave sleep. Br. J. Clin. Pharmacol. 31: 193, 1991.
Dugovic C., Wauquier A. 5-HT2 receptors could be primarily involved in the regulation of slow-wave sleep in the rat. Eur. J. Pharmacol. 137:145, 1987.
Van de Kar L.D., Wilkinson C.W., Skrobik Y., Brownfield M.S., Ganong W.F. Evidence that serotonergic neurons in the dorsal raphe nucleus exert a stimulatory effect on the secretion of renin but not of corticosterone. Brain. Res. 235: 233, 1982.
Rittenhouse P.A., Bakkum E.A., Levy A.D., Li Q., Yracheta J., Kunimoto K., Van de Kar L.D. Central stimulation of renin secretion through serotonergic non cardiovascular mechanisms. Neuroendocrinology 60: 205, 1994.
Rittenhouse P.A., Bakkum E.A., Van de Kar L.D., Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors. J. Pharmacol. Exp. Ther. 259: 58, 1991.
Dugovic C. Functional activity of 5-HT2 receptors in the modulation of the sleep/wakefulness states. J. Sleep Res. 1:163, 1992.
Rechtschaffen A., Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stage of Human Subjects. Washington DC., US Government Printing Office, 1968.
Cooley J.W., Tuckey J.W. An algorithm for the machine calculation of complex Fourier series. Math. Comp. 19: 297, 1965.
Van Cauter E. Quantitative methods for the analysis of circadian and episodic fluctuations. In: Van Cauter E., Copinschi G. (Eds.), Human pituitary hormones: circadian and episodic variations. Martinus Nijhoff, The Hague, 1981, p. 1.
Van de Kar L., Carnes M., Maslowski R.J., Bonadonna A.M., Rittenhouse P.A., Kunimoto K., Piechowski R.A., Bethea C.L. Neuroendocrine evidence for denervation supersensitivity of serotonin receptors: effects of the 5-HT agonist RU 24969 on corticotropin, corticosterone, prolactin and renin secretion. J. Pharmacol. Exp. Ther. 251: 428, 1989.
Idzikowski C., Mills F.J., Glennard R. 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep. Brain Res. 378: 164, 1986.
Solomon R.A., Sharpley A.L., Cowen P.J. 5-HT antagonists and slow wave sleep. Br. J. Clin. Pharmacol. 25: 125, 1988.
Mendlewicz J., Staner L., Kempenaers C., Simmonet M.P., Fransolet L. 5-HT2 receptor antagonism and slow wave sleep in man. In: Paoletti R., Vanhoute P.M., Brunello N., Maggi F.M. (Eds.), Serotonin: from cell biology to pharmacology and therapeutics. Kluwer Academic Publishers, Dordrecht, 1990, p. 523.
Adam K., Oswald I. Effects of repeated ritanserin on middle-aged poor sleepers. Psychopharmacology 99: 219, 1989.
Lammers G.J., Arends J., Declerck A.C., Kamphuisen H.A.C., Schouwink G., Troost J. Ritanserin, a 5-HT2 receptor blocker, as add -on treatment in narcolepsy. Sleep 14: 130, 1991.
Paiva T., Arriaga F., Wauquier A., Lara E., Largo R., Leitao J.N. Effects of ritanserin on sleep disturbances of dysthymic patients. Psychopharmacology 96: 395, 1988.
Dugovic C., Wauquier A. 5HT2 receptors could be primarily involved in the regulation of slow-wave sleep in the rat. Eur. J. Pharmacol. 137: 145, 1987.
Silhol S., Glin L., Gottesmann C. Study of the 5-HT2 antagonist ritanserin on sleep-waking cycle in the rat. Pharmacol. Biochem. Behav. 41: 241, 1991.
Borbely A., Trachsel A., Tobler I. Effect of ritanserin on sleep stages and sleep EEG in the rat. Eur. J. Pharmacol. 156: 275, 1988.
Monti J.M., Pineyro G., Orellana C., Boussard M., Jantos H., Labraga P., Olivera S., Alvarino F. 5-HT receptor agonists 1-(2,5-dimethoxy-4-iodophenyl)-2-amino-propane (DOI) and 8-OH-DPAT increase wakefulness in the rat. Bio. Amines 7: 145, 1990.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brandenberger, G., Luthringer, R., Muller, G. et al. 5-HT2 receptors are partially involved in the relationship between renin release and delta relative power. J Endocrinol Invest 19, 556–562 (1996). https://doi.org/10.1007/BF03349016
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349016